Drug intelligence / Profile preview

RTP-008

Development stage
Unknown
Lead developer
Raytone Biotech
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Ophthalmic, Implant
01

Overview

RTP-008 is a novel ophthalmic drug-device combination developed by Raytone Biotech (Zhejiang Ruitong Biotechnology) for the treatment of moderate-to-severe dry eye disease (DED). It consists of a bioabsorbable hydrogel-based punctal plug that is inserted into the lacrimal canaliculus. The device utilizes the proprietary iSus® platform to provide sustained local delivery of tacrolimus, a potent calcineurin inhibitor and immunosuppressant, while simultaneously providing physical tear retention through punctal occlusion. This dual mechanism aims to suppress ocular surface inflammation and improve tear film stability over several months with a single administration. As of August 2025, the candidate has entered clinical trials.

Other names
RTP-008RTP008RTP 008
02

Targets

CN (Calcineurin)

Beyond the preview

Go deeper on RTP-008.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RTP-008.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call